Marshall Fordyce
Net worth: 16 M $ as of 2026-06-29
Net worth: 16 M $ as of 2026-06-29
Marshall W.
Fordyce is the founder of Vera Therapeutics, Inc., founded in 2016, serving as President, Chief Executive Officer & Director.
The current job is Non-Executive Director at Albert & Mary Lasker Foundation since 2012.
Former job includes Senior Director-Clinical Research at Gilead Sciences, Inc. from 2011 to 2016.
Education includes undergraduate degree from Harvard University and doctorate from Harvard Medical School.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-07-06 | 374,024 ( 0.52% ) | 16 M $ | 2026-06-29 |
| Companies | Position | Start |
|---|---|---|
| VERA THERAPEUTICS, INC. | Founder | 2016-04-30 |
Albert & Mary Lasker Foundation
Albert & Mary Lasker Foundation The Albert & Mary Lasker Foundation is a company based in New York, NY. | Director/Board Member | 2012-03-31 |
| Companies | Position | End |
|---|---|---|
| GILEAD SCIENCES, INC. | Chief Tech/Sci/R&D Officer | 2016-06-30 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 5 |
|---|---|
Gilead Sciences, Inc.
Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Albert & Mary Lasker Foundation
Albert & Mary Lasker Foundation The Albert & Mary Lasker Foundation is a company based in New York, NY. | |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vera Therapeutics, Inc.
Vera Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company, which focuses on development and treatments for immunological & inflammatory diseases | Health Technology |
Select your edition
All financial news and data tailored to specific country editions